Andrew Malloy's Biography

Andrew Malloy, VP of Sales and Marketing, NanoView Biosciences

Andrew Malloy has been involved in scientific instrumentation in the EV field for more than a decade. Andrew was on of the early members of the NanoSight team who helped develop the NTA technology with the EV field. Since then Andrew has been involved in multiple technologies serving the EV field including super resolution microscopy and now is helping to ensure that the NanoView technology is aligned to the needs of the EV researcher both now and as the field progresses.

Multiparameter Phenotyping and Characterization of EVs - Direct from Complex Biofluids With No Purification

Monday, 9 September 2019 at 14:00

Add to Calendar ▼2019-09-09 14:00:002019-09-09 15:00:00Europe/LondonMultiparameter Phenotyping and Characterization of EVs - Direct from Complex Biofluids With No PurificationCirculating Biomarkers, Exosomes and Liquid Biopsy Asia 2019 in Seoul, KoreaSeoul, KoreaSELECTBIOenquiries@selectbiosciences.com

When studying EVs in a diagnostic capacity, understanding the nature and role of EV sub-populations is of paramount importance. Existing technologies either struggle to measure EVs due to their small size and/or are unable to link proteomic information to physical characterization at the single EV level. NanoView provides a multiparameter measurement of single EVs at the smallest sizes. The technology is able link proteomic information of surface and luminal proteins to physical characterization, without the need for any sample purification. Up to 4 surface and luminal proteins can be colocalized on single EVs

Add to Calendar ▼2019-09-09 00:00:002019-09-10 00:00:00Europe/LondonCirculating Biomarkers, Exosomes and Liquid Biopsy Asia 2019Circulating Biomarkers, Exosomes and Liquid Biopsy Asia 2019 in Seoul, KoreaSeoul, KoreaSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors